CN114317813A - Detection primer of swine influenza virus and kit thereof - Google Patents
Detection primer of swine influenza virus and kit thereof Download PDFInfo
- Publication number
- CN114317813A CN114317813A CN202011070178.5A CN202011070178A CN114317813A CN 114317813 A CN114317813 A CN 114317813A CN 202011070178 A CN202011070178 A CN 202011070178A CN 114317813 A CN114317813 A CN 114317813A
- Authority
- CN
- China
- Prior art keywords
- primer
- influenza virus
- swine influenza
- detection
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000725681 Swine influenza virus Species 0.000 title claims abstract description 51
- 238000001514 detection method Methods 0.000 title claims abstract description 46
- 230000003321 amplification Effects 0.000 claims abstract description 45
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 45
- 239000000523 sample Substances 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims description 21
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 13
- 238000010839 reverse transcription Methods 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 239000013641 positive control Substances 0.000 claims description 6
- 239000013642 negative control Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000002123 RNA extraction Methods 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 238000007403 mPCR Methods 0.000 claims description 4
- 238000000018 DNA microarray Methods 0.000 claims description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 abstract description 4
- 102000039446 nucleic acids Human genes 0.000 abstract description 4
- 150000007523 nucleic acids Chemical class 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000007847 digital PCR Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000003753 real-time PCR Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000011002 quantification Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 4
- 241000712461 unidentified influenza virus Species 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 206010069767 H1N1 influenza Diseases 0.000 description 3
- 241000712431 Influenza A virus Species 0.000 description 3
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 201000010740 swine influenza Diseases 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000001921 nucleic acid quantification Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Abstract
The invention provides a detection primer of swine influenza virus, which belongs to the technical field of gene detection, wherein the detection primer comprises a forward primer, a reverse primer and a probe primer for amplifying swine influenza virus genes; the kit can detect a swine influenza virus nucleic acid sample with low concentration, has high specificity and sensitivity and high primer amplification efficiency, greatly improves the detection rate of the swine influenza virus, and provides a reliable method for clinically detecting the swine influenza virus.
Description
Technical Field
The invention relates to the technical field of gene detection, in particular to primers and a kit for detecting swine influenza virus by digital PCR.
Background
Swine Influenza (SI) is an acute respiratory infectious disease of Swine caused by Swine Influenza Virus (SIV), and not only brings great harm to the Swine industry, but also seriously harms human health, thus drawing public health attention in the world. Infection with Swine Influenza Virus (SIV) can cause respiratory diseases characterized by respiratory diseases such as coughing, sneezing, runny nose, increased rectal temperature, drowsiness, dyspnea and loss of appetite. The virus is sensitive to heat, disinfectants, and is highly resistant to dryness and low temperatures. Swine influenza virus can be propagated on cells of various animals, but in virus isolation and vaccine production, chick embryo inoculation is often employed. The virus has hemagglutinating activity, but the antigenicity of different strains is not obviously distinguished. Because viruses are subjected to great stress by antibodies, viruses are subject to frequent mutation, the mechanisms of which involve antigenic drift and antigenic shift at the molecular level.
The swine influenza virus belongs to the genus influenza A virus of the family Orthomyxoviridae, and the virus particle is polymorphic. The genome comprises eight segmented negative strand RNAs encoding at least 12-13 proteins. Influenza a viruses can be classified into 16 HA subtypes (H1 to H16) and 9 NA subtypes (N1 to N9) according to the difference in virus surface glycoproteins. Influenza a viruses infect a variety of hosts including birds, pigs, and humans, among others. Because the respiratory epithelial cells of the pigs have receptors which are combined with the avian influenza virus and the human influenza virus, the human influenza virus and the avian influenza virus can infect the pigs. Also, more and more reports indicate that SIV can be transmitted back to birds and humans. Since 1974, SIV infected people have been reported worldwide and caused death in some cases. More importantly, influenza pandemic strains in 1957, 1968 and 2009 were all presumed to be associated with swine influenza virus. Three-source reassortment of swine influenza subtype variant strain H3N2/H1N2, which has received global attention since 8 months of 2011, caused infection of 318 persons in 13 areas of the United states, of which 1 person died and 16 persons were hospitalized.
In recent years, fluorescence quantitative PCR (polymerase chain reaction, QPCR) is a commonly used technical means for detecting and quantifying swine influenza virus, and the technique is characterized in that a fluorescence-labeled probe (such as TaqMan) is added into a PCR reaction system, a fluorescence signal accumulated in real time is utilized to monitor the whole amplification process, and finally, an unknown template is quantitatively analyzed through a standard curve so as to evaluate the amplification effect of PCR. Fluorescent quantitative PCR is a relatively quantitative method, which relies mainly on a standard curve prepared from a calibrator to determine the concentration of an unknown sample. There are numerous disadvantages to this technique: 1. the difference in background between the calibrator and the sample is liable to affect the efficiency and measurement response of PCR; 2. a low copy number of the target nucleic acid molecule cannot be detected by amplification; 3. the PCR amplification efficiency of the sample may be different from the amplification efficiency of the calibrator; impurities introduced into the RNA solution during RNA extraction or RNA degradation affect the PCR dynamic amplification process. Therefore, the detection and absolute quantification of the swine influenza virus with low copy number can hardly be achieved by the fluorescent quantitative PCR.
Digital polymerase chain reaction (dPCR) is a new technique for absolute quantification of single-molecule target nucleic acids. The technology is that a PCR solution containing a DNA template is diluted and then distributed to a large number of independent reaction chambers (such as chips), liquid molecules follow Poisson distribution, single molecules are separated by dilution, and PCR amplification is carried out independently, the distribution of the sample can greatly reduce the influence of background signals, improve the amplification sensitivity of low-abundance targets, finally each amplification product is analyzed, and the original copy number of the DNA template is calculated by a Poisson probability distribution formula without adopting a reference standard substance or an external standard substance. The detection rate is greatly improved, and the false negative detection level (single DNA template is present in the reaction chamber and is not detected) is very low. The method has the advantages of convenient operation, high detection flux, strong specificity, high sensitivity, accurate quantification and the like.
As a new technology for nucleic acid quantification, the digital PCR overcomes a series of defects of real-time fluorescence quantification PCR and realizes absolute quantification of single nucleic acid molecules. The problems that the standard curve used by the fluorescent quantitative PCR affects the measurement result and the like are avoided. The technology can replace fluorescent quantitative PCR to be applied to the quantitative detection of the swine influenza virus.
Disclosure of Invention
Based on the technical problems, the invention provides a group of PCR primers and probes with strong specificity and high amplification efficiency, and a high-sensitivity digital PCR technology is combined to achieve the purpose of detecting and absolutely quantifying the low-copy-value swine influenza virus.
The invention provides a detection primer of swine influenza virus, which comprises a forward primer, a reverse primer and an amplification probe primer of swine influenza virus, wherein the forward primer and the reverse primer are positioned at 34-54 and 115-135 basic groups of swine influenza virus genes, and the sequences of the forward primer and the reverse primer are shown as SEQ ID NO: 001 and SEQ ID NO: 002.
The amplification probe primer is positioned at 66-84 bases of a swine influenza virus gene, and the sequence of the amplification probe primer is shown as SEQ ID NO: 003. The primer amplification gene sequence is located at 34-135 bases of a new coronavirus gene, and the size of an amplification fragment is 102 bases, such as SEQ ID NO: 004.
In the above-mentioned swine influenza virus detection primer, the swine influenza virus primer sequence is selected from the group consisting of 34-54 and 115-135 bases of swine influenza virus genes in PubMed database, and the sequence thereof is shown as SEQ ID NO: 001 and SEQ ID NO: 002. The 3' end of the primer does not have self-complementary overlapping sequence, so that the generation of hairpin structure and primer dimer can be avoided.
In the swine influenza virus detection primer, the forward primer and the reverse primer are respectively shown as SEQ ID No.001 and SEQ ID No. 002.
SIV-forward: CTTTCTATCATCCCGTCAGGC (SEQ ID NO.001)
SIV-reverse: CCATTCCATGAGAGCCTCAAG (SEQ ID NO.002)
The sequence of the amplification probe primer is shown as SEQ ID NO. 003.
SIV-Probe: CGAGATCGCGCAGAGACTG (SEQ ID NO.003)
The sequence of the amplification region is shown as SEQ ID NO. 004.
Primer amplification sequence:
CTTTCTATCATCCCGTCAGGCCCCCTCAAAGCCGAGATCGCGCAGAGACTGGAAA GTGTCTTTGCAGGAAAGAACACAGATCTTGAGGCTCTCATGGAATGG(SEQ ID NO.004)
in the swine influenza virus detection primer, the use method of the detection primer comprises the following steps:
1) extracting sample RNA;
2) reverse transcription of RNA into cDNA;
3) using SEQ ID NO: the positive and reverse amplification primers and the amplification probe primer shown in 001-003-;
4) scanning and analyzing the amplification product in the step 3) by using a biochip reader to obtain a copy value of the amplification product.
The invention also provides a kit for detecting swine influenza virus, which comprises the detection primer.
Further, the detection kit comprises a sample RNA extraction reagent, an RNA reverse transcription reagent, absolute ethyl alcohol, a detection system PCR reaction solution, a positive reference substance and a negative reference substance;
wherein the PCR reaction solution of the detection system comprises: 1 pair of amplification primers and 1 probe primer, and the sequences are shown as SEQ ID NO: 001-.
Preferably, the detection system PCR reaction solution further comprises: 2x Multiplex PCR Plus Buffer; dNTP Mix; HotStar Taq Plus DNA Polymerase.
The invention designs the forward primer, the reverse primer and the probe primer for detecting the swine influenza virus, and can be simultaneously used for fluorescent quantitative PCR and digital PCR amplification reaction. The amplification efficiency of the primer is better than that of other primers through fluorescent quantitative PCR amplification comparison. The absolute copy value of the swine influenza virus can be accurately detected by performing digital PCR detection on the plasmid standard product and the submission sample. The amplification efficiency can be optimized by adjusting the reaction conditions such as the concentration of forward and reverse primers and probes, the annealing temperature and the like.
The invention has the following beneficial effects: the designed forward and reverse amplification primers for the swine influenza virus can efficiently amplify a target gene, have high specificity and accuracy, and have higher amplification efficiency than other amplification primers; the method for amplifying the target gene by adopting the digital PCR method has the advantages of high sensitivity, absolute quantification and the like. Greatly improves the detection efficiency of the swine influenza virus and provides a reliable method for clinically detecting the swine influenza virus.
Description of the drawings:
FIG. 1 is a comparison of the amplification of an example of the invention with a literature reporter primer;
Detailed Description
The following preferred embodiments are merely illustrative of the technical solutions of the present invention and are not restrictive, and although the present invention has been described in detail with reference to the following preferred embodiments, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the present invention as defined by the appended claims.
Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings. It should be noted that the embodiments and features of the embodiments in the present application may be arbitrarily combined with each other without conflict.
Example 1
Primer sequence for detecting amplification of swine influenza virus
Comprises the amino acid sequence of SEQ ID NO: 001-003 is a sequence of a forward primer, a reverse primer and a probe primer for amplifying the swine influenza virus.
The forward and reverse primers designed by the invention have random base distribution, 3 'ends of the primers do not have continuous 3 or more GC base aggregation, and the 3' ends do not have self-complementary overlapping sequences, so that hairpin structures and primer dimers can be avoided. Related literature (PMC7119756) reports primers as set forth in SEQ ID NO: 005-007, the forward and reverse primers have too high GC content, so that primer dimers are easily generated, which is not favorable for the fluorescent quantitative PCR amplification.
The literature reports forward primers: TCAGGCCCCCTCAAAGCCGA (SEQ ID NO.005)
The literature reports reverse primers: GGGCACGGTGAGCGTGAACA (SEQ ID NO.006)
The literature reports that probes: CGCGCAGAGACTGGAAAGTGTC (SEQ ID NO.007)
In the detection, the forward and reverse primers and the probe primers described in the above claims are compared with the primer probes of the related literature, the artificial synthetic swine influenza virus gene (Shanghai bioengineering GmbH) is used as a template, and simultaneously, the fluorescence quantitative PCR amplification is carried out to obtain an amplification curve chart (figure 1), and the amplification efficiency of the primers described in the above claims is obviously better than that of the primers reported in the literature.
Example 2
Detection kit for testing swine influenza virus based on digital PCR technology
The method comprises the following steps: a sample RNA extraction kit (Kajie's RNA extraction kit, cat No. 52904); absolute ethyl alcohol; RNA reverse transcription kit (Kajie's reverse transcription kit, cat # 205411); digital PCR micro-drop chip kit (chip kit provided by Hangzhou navigation Gene Co., Ltd., product number D1); a detection system PCR reaction solution, a positive control substance and a negative control substance. Wherein the PCR reaction solution of the detection system comprises: 2x Multiplex PCR Plus Buffer; dNTP Mix; HotStar Taq Plus DNA Polymerase; SEQ ID NO: 001-003 of the sequence of the primer pair.
Example 3
Method for detecting swine influenza virus based on microdroplet digital PCR technology
(1) Extraction of genomic RNA from throat swab standards
1) 560. mu.L of Buffer AVL primed with Carrier RNA was pipetted into a 1.5ml centrifuge tube.
2) Add 140. mu.L throat swab standard and vortex mix for 15 s.
3) Incubate at room temperature for 10 min.
4) A brief centrifugation concentrates the adhering droplets on the inner wall of the centrifuge tube to the bottom of the tube.
5) Add 560. mu.l of absolute ethanol and mix by vortexing for 15 s.
6) Aspirate 630. mu.l of step 5, add to the filter column in a 2ml collection tube, cap, and centrifuge at 6000Xg (8000 rpm) for 1 minute.
7) And 6, repeating the step.
8) Add 500. mu.l Buffer AW1, 6000Xg (8000 rpm) and centrifuge for 1 min.
9) Add 500. mu.l Buffer AW2, 20000Xg (14000 rpm) and centrifuge for 3 minutes.
10) The filter column was placed in a fresh 1.5ml sterile centrifuge tube and 60. mu.l Buffer AVE added and incubated for 1min at room temperature.
11) The sample lysates were collected by centrifugation at 6000Xg (8000 rpm) for 1 minute.
(2) Reverse transcription of RNA
1) The RNA sample, Reverse Transcription Mix and RNase-free water were thawed at room temperature, and gDNA remove Mix and Reverse Transcription Enzyme were placed on ice in advance.
2) A genome DNA-free reaction liquid system was prepared as follows
3) Incubate at 45 ℃ for 2min and immediately place on ice for use.
4) The reverse transcription reaction liquid system is prepared according to the following table
Name of reagent | Dosage of |
Reverse Transcription Enzyme | 1μl |
Reverse Transcription Mix | 4μl |
Template RNA(step 3) | 15μl |
Total of | 20μl |
5) After mixing, the reaction is carried out according to the following procedure
Step | Time | Temperature |
Annealing step | 3min | 25℃ |
Reverse-transcription step | 10min | 45℃ |
Inactivation of reaction | 5min | 85℃ |
(3) Preparing a reagent:
the detection system PCR reaction solution is prepared as follows:
name of reagent | Dosage of |
2X Multiplex PCR Master Mix | 12.5μl |
Forward primer (6. mu.M) | 2.5μl |
Reverse primer (6. mu.M) | 2.5μl |
Probe primer (3. mu.M) | 2.5μl |
Sample cDNA template | 5.0μl |
Total of | 25.0μl |
Wherein, the base sequences of the forward and reverse amplification primers and the probe primers are shown as SEQ ID NO: 001-.
Preparing PCR reaction liquid X mu l according to the parts of detected samples, and subpackaging 20 mu l of each part:
x20. mu.l reaction solution X (n specimen +1 part positive control +1 part negative control)
And n is the number of detected samples.
(4) Sample adding: adding 5 mu l of the cDNA sample obtained in the step (2) into a PCR reaction solution of a detection system; for positive control experiments, 5 mul of positive control substance is directly added; for the negative control experiment, 5. mu.l ddH2O was added directly.
(5) Loading a chip: and (3) sucking 14 mu l of the PCR reaction solution prepared in the step (4) by using a pipette, loading the sample into a chip, adding 16 mu l of glycerin to seal the chip, and placing the chip on a droplet generator to generate droplets.
(6) Digital PCR amplification: the amplification was performed on a PCR instrument dedicated to the droplet chip, using a TC1.0 PCR instrument (Hangzhou navigation Gene technology Co., Ltd.). The reaction conditions were as follows: pre-denaturation at 95 ℃ for 5 min and 30 sec; 45 cycles of 95 ℃ for 30 seconds, 55 ℃ for 90 seconds, and 72 ℃ for 30 seconds; storing at 4 ℃.
(7) Fluorescence scanning and image analysis:
and (4) placing the chip amplified in the step (6) in a biochip reader for fluorescence scanning photographing and data analysis, and calculating the absolute copy number of the swine influenza virus molecules in the sample after the analysis is finished.
Example 4
The swine influenza virus detection kit based on the digital PCR technology is adopted to detect clinical specimens.
12 samples of the pharyngeal swab were taken, 7 positive samples and 5 negative samples were confirmed clinically. The 12 samples were reverse transcribed by RNA extraction, reagent preparation and detection as described in example 3. Each sample is added into 5 mul of PCR reaction solution of the detection system, and positive and negative controls are performed at the same time. Each sample was repeated 2 times. The detection results of the digital PCR primers show that 7 positive cases and 5 negative cases are consistent with the diagnosis result, and the accuracy rate is 100%. The result of primer detection reported in literature shows 4 positive cases and 8 negative cases, and the accuracy rate is 75.0%. The detection result of the digital PCR primer is obviously higher than that of a primer reported in the literature.
The test results are shown in the following table 1:
the above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (6)
1. The detection primer of the swine influenza virus is characterized by comprising a forward primer, a reverse primer and an amplification probe primer of the swine influenza virus, wherein the sequence of the swine influenza virus primer is derived from 34-54 and 115-135 basic groups of a swine influenza virus genome in an international PubMed database, and the NCBI code of the genome number is FJ 966975.
2. The detection primer as claimed in claim 1, wherein the forward primer and the reverse primer are located at bases 34-54 and 115-135 of the swine influenza virus gene, and the sequences are shown as SEQ ID NO: 001 and SEQ ID NO: 002 shows that the amplification probe primer is located at 66-84 bases of swine influenza virus gene, and the sequence is shown as SEQ ID NO: 003.
3. The detection primer according to claim 1, wherein the detection primer is used by a method comprising:
1) extracting sample RNA;
2) reverse transcription of RNA into cDNA;
3) using SEQ ID NO: the positive and reverse amplification primers and the amplification probe primer shown in 001-003-;
4) scanning and analyzing the amplification product in the step 3) by using a biochip reader to obtain a copy value of the amplification product.
4. A kit for detecting swine influenza virus, comprising the detection primer of any one of claims 1 to 3.
5. The swine influenza virus detection kit of claim 4, wherein the detection kit comprises a sample RNA extraction reagent, an RNA reverse transcription reagent, absolute ethanol, a detection system PCR reaction solution, a positive control and a negative control;
wherein the PCR reaction solution of the detection system comprises: 1 pair of amplification primers and 1 probe primer, and the sequences are shown as SEQ ID NO: 001-.
6. The kit according to claim 4, wherein the detection system PCR reaction solution further comprises: 2x Multiplex PCR Plus Buffer; dNTP Mix; HotStar Taq Plus DNA Polymerase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011070178.5A CN114317813A (en) | 2020-10-10 | 2020-10-10 | Detection primer of swine influenza virus and kit thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011070178.5A CN114317813A (en) | 2020-10-10 | 2020-10-10 | Detection primer of swine influenza virus and kit thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114317813A true CN114317813A (en) | 2022-04-12 |
Family
ID=81032893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011070178.5A Withdrawn CN114317813A (en) | 2020-10-10 | 2020-10-10 | Detection primer of swine influenza virus and kit thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114317813A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101864495A (en) * | 2010-04-13 | 2010-10-20 | 上海国际旅行卫生保健中心 | Constant-temperature amplification detection kit of influenza A virus and detection method thereof |
CN102146485A (en) * | 2011-03-24 | 2011-08-10 | 武汉大学 | One-step RT-PCR (Reverse Transcription-Polymerase Chain Reaction) detection kit for influenza virus |
US20130296181A1 (en) * | 2010-07-12 | 2013-11-07 | Gen-Probe Incorporated | Compositions and assays to detect swine h1n1 influenza a virus, seasonal h1 influenza a virus and seasonal h3 influenza a virus nucleic acids |
CN104450956A (en) * | 2014-11-12 | 2015-03-25 | 中国农业科学院哈尔滨兽医研究所 | Real-time fluorescence RT-PCR detection kit for H1N1 type A swine influenza virus and application of detection kit |
-
2020
- 2020-10-10 CN CN202011070178.5A patent/CN114317813A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101864495A (en) * | 2010-04-13 | 2010-10-20 | 上海国际旅行卫生保健中心 | Constant-temperature amplification detection kit of influenza A virus and detection method thereof |
US20130296181A1 (en) * | 2010-07-12 | 2013-11-07 | Gen-Probe Incorporated | Compositions and assays to detect swine h1n1 influenza a virus, seasonal h1 influenza a virus and seasonal h3 influenza a virus nucleic acids |
CN102146485A (en) * | 2011-03-24 | 2011-08-10 | 武汉大学 | One-step RT-PCR (Reverse Transcription-Polymerase Chain Reaction) detection kit for influenza virus |
CN104450956A (en) * | 2014-11-12 | 2015-03-25 | 中国农业科学院哈尔滨兽医研究所 | Real-time fluorescence RT-PCR detection kit for H1N1 type A swine influenza virus and application of detection kit |
Non-Patent Citations (1)
Title |
---|
唐连飞等: "数字RT-PCR技术检测H3N2亚型猪流感病毒方法的建立", 中国畜牧兽医, vol. 44, no. 6, pages 1847 - 1853 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021174674A1 (en) | Composition, kit and method for detecting and typing coronaviruses | |
JP6329370B2 (en) | Simultaneous diagnosis kit for diseases caused by respiratory viruses | |
CN111187858A (en) | Novel coronavirus detection kit | |
CN106435024B (en) | Fluorescent quantitative PCR primer, probe, kit and detection method for detecting avian influenza virus subtype | |
WO2022057060A1 (en) | Method and kit for multiple detection of respiratory virus nucleic acids | |
CN111500776A (en) | Novel coronavirus 2019-nCoV fluorescent RPA detection primer, probe, kit and method | |
EP1761645A1 (en) | Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1 | |
CN104232798B (en) | The multiple fluorescence quantitative PCR method of DHAV detection and Gene A type and the discriminating of C type and test kit | |
JP7064473B2 (en) | How to detect influenza A virus and influenza B virus | |
CN112176112A (en) | Triple fluorescent quantitative RT-PCR detection kit for avian influenza virus H5, H7 and H9 subtypes and application thereof | |
CN113652505A (en) | Method and kit for detecting novel coronavirus and VOC-202012/01 mutant strain thereof | |
CN112739833A (en) | Primer pair, probe and kit for detecting SARS-CoV-2 by utilizing nested RPA technology and application thereof | |
CN113564280A (en) | RAA primer for detecting 12 serotypes of avian adenovirus group I and detection method thereof | |
Guionie et al. | Laboratory evaluation of a quantitative real-time reverse transcription PCR assay for the detection and identification of the four subgroups of avian metapneumovirus | |
Mo et al. | Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens | |
Sun et al. | Development and evaluation of a sensitive and quantitative assay for hirame rhabdovirus based on quantitative RT-PCR | |
Li et al. | Development of a multiplex real-time polymerase chain reaction for the detection of influenza virus type A including H5 and H9 subtypes | |
CN110527747B (en) | Kit for detecting wild strains of classical swine fever viruses | |
CN114317813A (en) | Detection primer of swine influenza virus and kit thereof | |
CN108411042A (en) | A kind of fluorescence quantification PCR primer and kit of detection japanese encephalitis virus | |
CN114032337A (en) | Respiratory tract pathogen detection kit and preparation method and application thereof | |
Callison et al. | Rapid differentiation of avian infectious bronchitis virus isolates by sample to residual ratio quantitation using real-time reverse transcriptase-polymerase chain reaction | |
CN107267666A (en) | A kind of fluorescent quantitation RT PCR detection kits based on pig atypia pestivirus raq gene | |
CN111363849A (en) | Novel coronavirus nucleic acid detection kit and detection method | |
CN113025746B (en) | Method for detecting REV by NASBA and kit used by same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20220412 |
|
WW01 | Invention patent application withdrawn after publication |